Philips, Janssen Pharmaceutical enter into multi-year collaboration to develop blood-based diagnostic for brain disorders
Philips has signed a multi-year partnership deal with Janssen Pharmaceutical, a Johnson & Johnson company, to develop a handheld diagnostic test for diagnosis of brain disorders from blood samples. The device will be based on the platform of Philips’ Minicare system. As per the agreement terms, Philips will develop the diagnostic test followed by Janssen to conduct clinical trials and market the product. The device will comprise up of a handheld analyzer, software and single use disposable cartridges. The device under development will be used in hospitals for the diagnosis and management of chronic diseases such as neuropsychiatric disorders. The new device will be expected to perform equivalent to cardiac markers in terms of result accuracy with less time and less blood sample requirement. Both companies have not disclosed the financial terms of the deal.